ArticleClinical and experimental immunology2009

An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease.

A Lemmers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.